Interleukin-6 Enhances Glucose-Stimulated Insulin Secretion From Pancreatic β-Cells
Open Access
- 21 January 2011
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 60 (2), 537-547
- https://doi.org/10.2337/db10-0796
Abstract
OBJECTIVE: Interleukin-6 (IL-6) has a significant impact on glucose metabolism. However, the effects of IL-6 on insulin secretion from pancreatic β-cells are controversial. Therefore, we analyzed IL-6 effects on pancreatic β-cell functions both in vivo and in vitro. RESEARCH DESIGN AND METHODS: First, to examine the effects of IL-6 on in vivo insulin secretion, we expressed IL-6 in the livers of mice using the adenoviral gene transfer system. In addition, using both MIN-6 cells, a murine β-cell line, and pancreatic islets isolated from mice, we analyzed the in vitro effects of IL-6 pretreatment on insulin secretion. Furthermore, using pharmacological inhibitors and small interfering RNAs, we studied the intracellular signaling pathway through which IL-6 may affect insulin secretion from MIN-6 cells. RESULTS: Hepatic IL-6 expression raised circulating IL-6 and improved glucose tolerance due to enhancement of glucose stimulated-insulin secretion (GSIS). In addition, in both isolated pancreatic islets and MIN-6 cells, 24-h pretreatment with IL-6 significantly enhanced GSIS. Furthermore, pretreatment of MIN-6 cells with phospholipase C (PLC) inhibitors with different mechanisms of action, U-73122 and neomycin, and knockdowns of the IL-6 receptor and PLC-β1, but not with a protein kinase A inhibitor, H-89, inhibited IL-6–induced enhancement of GSIS. An inositol triphosphate (IP3) receptor antagonist, Xestospondin C, also abrogated the GSIS enhancement induced by IL-6. CONCLUSIONS: The results obtained from both in vivo and in vitro experiments strongly suggest that IL-6 acts directly on pancreatic β-cells and enhances GSIS. The PLC-IP3–dependent pathway is likely to be involved in IL-6-mediated enhancements of GSIS.Keywords
This publication has 59 references indexed in Scilit:
- Central Exercise Action Increases the AMPK and mTOR Response to LeptinPLOS ONE, 2008
- Interleukin-6 regulates pancreatic α-cell mass expansionProceedings of the National Academy of Sciences of the United States of America, 2008
- Abnormal glucose homeostasis in skeletal muscle–specific PGC-1α knockout mice reveals skeletal muscle–pancreatic β cell crosstalkJCI Insight, 2007
- The role of interleukin‐6 in insulin resistance, body fat distribution and energy balanceObesity Reviews, 2007
- Oleic acid interacts with GPR40 to induce Ca2+signaling in rat islet β-cells: mediation by PLC and L-type Ca2+channel and link to insulin releaseAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Constitutively active PDX1 induced efficient insulin production in adult murine liverBiochemical and Biophysical Research Communications, 2005
- IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivoTransplant Immunology, 2004
- Disruption of the WFS1 gene in mice causes progressive -cell loss and impaired stimulus-secretion coupling in insulin secretionHuman Molecular Genetics, 2004
- Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40Nature, 2003
- Overexpression of Catalytic Subunit p110α of Phosphatidylinositol 3-Kinase Increases Glucose Transport Activity with Translocation of Glucose Transporters in 3T3-L1 AdipocytesPublished by Elsevier BV ,1996